China sees new COVID-19 outbreaks as Shanghai starts massive booster campaign using new inhalation doses
Beijing, China – In Shanghai city He announced the first large-scale COVID-19 inhalation campaign. All residents over 17 years of age who did not receive a booster dose were told to enroll through an app. The new method of reinforcement comes as Shanghai is once again dealing with the recent COVID outbreak.
Within the first hour, most news-related comment sections were blocked on social media. And they had good reason to do so. Few comments left on Twitter in China Social media platform, Weibo, Show mainly concerned citizens. One person wrote: “I support the vaccination campaign, but will the result be good this time?” Another comment says, “Does it even matter if I take it or not?”.
Once the comment sections reopened, the messages suddenly became more positive. With the hashtag “Shanghai launches new inhalation crown-shaped vaccine”, the number of views has reached 4.3 million.
China has been working on an inhaler booster for more than a year. The booster created by Shanghai Shangyao Kangxinuo Biopharm Pharmaceutical, called the type 5 adenovirus vector, is inhaled via an aspirator. A press release from the company stated that the booster uses so-called engineered viruses (adenovirus vectors) that are harmless to the body. The engineered viruses carry a genetic code that leads to a higher immune response over time.
The company’s press release said studies have shown that after six months of using the inhaler, in combination with regular COVID vaccines, high levels of neutralizing antibodies were maintained within the body. There are no exact efficacy rates for an inhaler booster.
in September , China National Medical Products Administration Approved the first inhaled COVID vaccine produced by CanSino Biologics. It is not known how many people have received the booster inhaler so far.
“Previous COVID-19 vaccines made in China have been ineffective compared to Western vaccines. In fact, China has moved more in the direction of using mRNA vaccines. Fox News medical contributor Dr. Mark Siegel told Fox News Digital that their zero-coronavirus strategy was a complete failure, due to the ease with which the omicron variant spreads.
Siegel added, “They have now come up with the first nasal vaccine, which attacks SARS-CoV2 at the level of the nose or mucosa. If it is effective, it could significantly reduce its spread. But most likely, it will only be partially effective.” All eyes are on Dr. Akiko Iwasaki at Yale University, who is one of our top virologists and is currently studying a nasal septum vaccine that stimulates antibodies on contact.”
The new inhaler comes just in time for Shanghai. Official statistics show that more than 23 million of the 24.9 million residents in Shanghai have now been fully vaccinated. About half of the 23 million people received a booster shot. However, Shanghai is still struggling to maintain the city COVID-19 Free. On Tuesday, the city counted 36 confirmed cases, enough to classify 18 parts of the city as “medium risk areas.”
An area is classified as moderate risk if a person infected with the COVID virus, with or without symptoms, lives in or passes through the area. All people living in that area will be required to stay within their residential area and, in most cases, undergo daily COVID tests. If no new infections are found in the relevant area for seven consecutive days, the area will be declared low risk.
Earlier this month, the Associated Press reported that outbreaks were reported across the country, with the largest numbers occurring in Inner Mongolia and in the Xinjiang region both recording several hundred cases per day.
The Associated Press contributed to this report.